Sickle cell disease today: a 75-year journey from "first molecular disease" to "first gene-editing therapy"

Affiliations

• ¹ Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
• ² Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
• ³ Department of Paediatrics and Medical Research Council Molecular Haematology Unit, Weatherhall Institute of Molecular Medicine, Oxford University, Oxford, United Kingdom.